Want to join the conversation?
$XRAY 2Q15 Call: Gross profit rate on an adjusted basis was 60.2% of sales, excluding precious metals, an improvement of 170 BP over 2Q14. SG&A expenses on an adjusted basis were 39.1% of sales, excluding precious metals, down 10 BP vs. 2Q14. Restructuring and other cost were $38.9MM. Operating cash flow was $145.8MM, down $9.9MM vs. 2Q14.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.